Showing results (291-300 of 333) with videos related to

Sort By:
Pageof 34
Clinical Lung Cancer|January 3, 2026
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424LShunichi Kataoka, Takehito Shukuya, Hiroshi Ohtsu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2023
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trialHisato Kawakami, Yu Sunakawa, Eisuke Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2024
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2018
B7-H3 Negatively Modulates CTL-Mediated Cancer ImmunityKimio Yonesaka, Koji Haratani, Shiki Takamura, et al.
JAMA Network Open|November 12, 2025
Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non-Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical TrialsPasi A Jänne, David Planchard, Koichi Goto, et al.
JTO Clinical and Research Reports|May 30, 2023
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in JapanYasushi Goto, Hirotsugu Kenmotsu, Motohiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysisHidetoshi Hayashi, Byoung Chul Cho, Yu Jung Kim, et al.
The European Respiratory Journal|April 1, 2022
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trialKohei Otsubo, Junji Kishimoto, Masahiko Ando, et al.
Cancer Science|July 5, 2018
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutationsHaruyasu Murakami, Hiroshi Nokihara, Hidetoshi Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2025
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and ImmunotherapyConor E Steuer, Hidetoshi Hayashi, Wu-Chou Su, et al.
Pageof 34